Randomized phase 2 trial of ixazomib and dexamethasone in relapsed multiple myeloma not refractory to bortezomib

Shaji K. Kumar, Betsy R. LaPlant, Craig B. Reeder, Vivek Roy, Alese E. Halvorson, Francis Buadi, Morie A. Gertz, P. Leif Bergsagel, Angela Dispenzieri, Melanie A. Thompson, Jamie Crawley, Prashant Kapoor, Joseph Mikhael, Keith Stewart, Suzanne R. Hayman, Yi L. Hwa, Wilson Gonsalves, Thomas E. Witzig, Sikander Ailawadhi, David DingliRonald S. Go, Yi Lin, Candido E. Rivera, S. Vincent Rajkumar, Martha Q. LacyShow 5 othersShow less